MARKET

FBIO

FBIO

Fortress Biotech Inc
NASDAQ
2.760
-0.260
-8.61%
After Hours: 2.770 +0.01 +0.36% 19:13 06/26 EDT
OPEN
3.000
PREV CLOSE
3.020
HIGH
3.060
LOW
2.700
VOLUME
1.10M
TURNOVER
--
52 WEEK HIGH
4.530
52 WEEK LOW
1.700
MARKET CAP
91.68M
P/E (TTM)
0.8690
1D
5D
1M
3M
1Y
5Y
1D
Corbus Pharmaceuticals Holdings Inc. Stock Rises 5.9%, Outperforms Peers
Dow Jones · 1d ago
Journey Medical holds annual shareholder meeting online
PUBT · 2d ago
Fortress Biotech holds annual shareholder meeting
PUBT · 4d ago
Weekly Report: what happened at FBIO last week (0615-0619)?
Weekly Report · 6d ago
Corbus Pharmaceuticals Holdings Inc. Stock Sheds 5.3%, Underperforms Peers
Dow Jones · 06/16 20:34
Weekly Report: what happened at FBIO last week (0608-0612)?
Weekly Report · 06/15 10:09
Corbus Pharmaceuticals Holdings Inc. Stock Rises 5.3%, Outperforms Peers
Dow Jones · 06/12 20:34
Quant rating check: Top oncology peers as Nuvalent goes private in $10.6B deal with GSK
Seeking Alpha · 06/09 09:18
More
About FBIO
Fortress Biotech, Inc. is a biopharmaceutical company focused on acquiring and advancing assets. The Company has eight marketed prescription pharmaceutical products and over 20 programs in development, with its majority-owned and majority-controlled partners and subsidiaries and partners and subsidiaries it founded and in which it holds significant minority ownership positions. Its portfolio is being commercialized and developed for various therapeutic areas, including oncology, dermatology, and rare diseases. Its dermatology products include Emrosi, Qbrexza, Amzeeq, Zilxi, Exelderm, Targadox, and Luxamend. Its late-stage product candidates include CUTX-101 (copper histidinate injection for Menkes disease), Triplex (cytomegalovirus (CMV) vaccine), and CAEL-101 (monoclonal antibody for AL amyloidosis). Its early and mid-stage product candidates include Dotinurad (urate transporter (URAT1) inhibitor for gout), MB-101 (IL13Rα2 CAR T Cell Program for Glioblastoma), and others.

Webull offers Fortress Biotech Inc stock information, including NASDAQ: FBIO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FBIO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading FBIO stock methods without spending real money on the virtual paper trading platform.